In a filing, Rocket Pharmaceuticals Inc revealed its Director Makker Gotham unloaded Company’s shares for reported $7.79 million on Mar 21 ’24. In the deal valued at $28.43 per share,274,000 shares were sold. As a result of this transaction, Makker Gotham now holds 365,912 shares worth roughly $8.92 million.
Then, Militello John sold 2,490 shares, generating $69,979 in total proceeds. Upon selling the shares at $28.10, the insider now owns 55,239 shares.
Before that, Militello John sold 10,000 shares. Rocket Pharmaceuticals Inc shares valued at $298,450 were divested by the insider at a price of $29.84 per share. As a result of the transaction, Militello John now holds 21,517 shares, worth roughly $0.52 million.
Goldman initiated its Rocket Pharmaceuticals Inc [RCKT] rating to a Neutral in a research note published on April 02, 2024; the price target was $39. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in late October with a ‘”an Overweight”‘ rating. Morgan Stanley began covering RCKT with “an Overweight” recommendation on February 01, 2023. Canaccord Genuity started covering the stock on November 08, 2022. It rated RCKT as “a Buy”.
Price Performance Review of RCKT
On Monday, Rocket Pharmaceuticals Inc [NASDAQ:RCKT] saw its stock fall -2.48% to $24.39. Over the last five days, the stock has lost -8.72%. Rocket Pharmaceuticals Inc shares have fallen nearly -18.62% since the year began. Nevertheless, the stocks have risen 47.02% over the past one year. While a 52-week high of $32.53 was reached on 02/27/24, a 52-week low of $14.89 was recorded on 04/05/24. SMA at 50 days reached $28.08, while 200 days put it at $22.82. A total of 0.73 million shares were traded, compared to the trading of 0.52 million shares in the previous session.
Levels Of Support And Resistance For RCKT Stock
The 24-hour chart illustrates a support level at 24.10, which if violated will result in even more drops to 23.81. On the upside, there is a resistance level at 24.94. A further resistance level may holdings at 25.48. The Relative Strength Index (RSI) on the 14-day chart is 31.57, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.60, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 96.83%. Stochastics %K at 7.41% indicates the stock is a buying.
How much short interest is there in Rocket Pharmaceuticals Inc?
A steep rise in short interest was recorded in Rocket Pharmaceuticals Inc stocks on Mar 15, 2024, growing by 1.04 million shares to a total of 10.24 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 9.2 million shares. There was a rise of 10.16%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 14.74% of the overall stock float, the days-to-cover ratio (short ratio) rose to 12.05.
The most recent change occurred on November 01, 2022 when BTIG Research began covering the stock and recommended ‘”a Buy”‘ rating along with a $35 price target.
